Gene · 3601
IL15RA: interleukin 15 receptor subunit alpha
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. IL15RA: interleukin 15 receptor subunit alpha. Genes, record 3601. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3601
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q13261 | Interleukin-15 receptor subunit alpha | 267 | 4 | Ensembl, GeneID, HGNC |
Source UniProt
Patents425
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4808601 A1 | 2026-09-23 | 200 | Q13261 | Espacenet |
| WO 2026183237 A1 | 2026-09-03 | 266 | Q13261 | Espacenet |
| EP 4795154 A1 | 2026-08-26 | 26 | Q13261 | Espacenet |
| EP 4791785 A1 | 2026-08-19 | 11 | Q13261 | Espacenet |
| EP 4791785 A1 | 2026-08-19 | 4 | Q13261 | Espacenet |
| US 12653839 B2 | 2026-06-16 | 200 | Q13261 | Espacenet |
| JP 2026076241 A | 2026-05-11 | 3 | Q13261 | Espacenet |
| JP 2026076241 A | 2026-05-11 | 7 | Q13261 | Espacenet |
| JP 2026076241 A | 2026-05-11 | 1116 | Q13261 | Espacenet |
| JP 2026513839 A | 2026-05-01 | 364 | Q13261 | Espacenet |
1 to 10 of 425
See all 425 patentsDrugs2
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
Trials35
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT07578558 | NOGAPENDEKIN ALFA INBAKICEPT | PHASE2 | ClinicalTrials.gov | |
| NCT07524257 | NOGAPENDEKIN ALFA INBAKICEPT | PHASE3 | ClinicalTrials.gov | |
| NCT07492888 | NOGAPENDEKIN ALFA INBAKICEPT | PHASE2 | ClinicalTrials.gov | |
| NCT07492875 | NOGAPENDEKIN ALFA INBAKICEPT | PHASE3 | ClinicalTrials.gov | |
| NCT07488884 | NOGAPENDEKIN ALFA INBAKICEPT | PHASE1 | ClinicalTrials.gov | |
| NCT07355205 | NOGAPENDEKIN ALFA INBAKICEPT | PHASE1/PHASE2 | ClinicalTrials.gov | |
| NCT07261657 | NOGAPENDEKIN ALFA INBAKICEPT | EARLY_PHASE1 | ClinicalTrials.gov | |
| NCT07217496 | NOGAPENDEKIN ALFA INBAKICEPT | PHASE1 | ClinicalTrials.gov | |
| NCT07145164 | RECOMBINANT HUMAN INTERLEUKIN-15 | PHASE2 | ClinicalTrials.gov | |
| NCT06995872 | RECOMBINANT HUMAN INTERLEUKIN-15 | PHASE1 | ClinicalTrials.gov |
1 to 10 of 35
See all 35 trialsNIH grants2,033
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | IL15RA papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 24 | 2025 |
| P01CA111412 | NK cells, their receptors and cancer therapy | 16 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 14 | 2025 |
| P01CA065493 | Off-the-Shelf Immune Effector Cells for Hematological Malignancies | 13 | 2025 |
| P01CA163205 | Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas | 8 | 2025 |
| ZIABC010334 | Conserved Element DNA Vaccine | 8 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 7 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 7 | 2025 |
| P50CA171963 | Specialized Program of Research Excellence (SPORE) in Leukemia | 7 | 2025 |
| ZIABC010944 | Strategies for Cancer Immunotherapy Development: Preclinical Studies | 7 | 2025 |
1 to 10 of 2,033Source NIH's project files
See all 2,033 nih grantsPapers2,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IL-15 trans-presentation at the innate-adaptive interface: mechanisms and translation in cancer immunotherapy. | Oncoimmunology | 2026 | 42771543 | PubTator, text mining | PubMed |
| Enhancing HIV-1-specific CAR-T cell functional activity by treatment with a novel cytokine-based scaffold with IL-15 superagonist and TGF-β-neutralizing activity. | J Virol | 2026 | 42599109 | PubTator, text mining | PubMed |
| The gut-immune-brain axis in CNS tumors: Causal roles of microbiota and inflammatory proteins unveiled by Mendelian randomization and single-cell transcriptomics. | Medicine (Baltimore) | 2026 | 42566596 | PubTator, text mining | PubMed |
| Causal relationship between 91 circulating inflammatory proteins and osteomyelitis risk: evidence from a Mendelian randomization study. | Arch Med Sci | 2026 | 42540617 | PubTator, text mining | PubMed |
| EBER-associated promoter contacts mark accessible but transcriptionally constrained RNAPII promoter hubs in EBV-positive B cells. | Epigenetics Chromatin | 2026 | 42477823 | PubTator, text mining | PubMed |
| Armed Oncolytic Myxoma Virus Induces Systemic Antitumor Immunity Against Solid Tumors in Immunocompetent Mice. | Res Sq | 2026 | 42466427 | PubTator, text mining | PubMed |
| Synergistic Oncolytic Effect of HSVtk- and IL-15Rα-Armed Vaccinia Viruses Inducing Systemic Antitumor Immunity. | Int J Mol Sci | 2026 | 42450112 | PubTator, text mining | PubMed |
| Serum Proteomic Profiles of Microvascular Inflammation in Donor-specific Antibody-negative and C4d-negative in Kidney Transplantation. | Transplantation | 2026 | 42441560 | PubTator, text mining | PubMed |
| Engineering with EP2/EP4 knockout and IL-15 transpresentation renders stem cell-derived NK cells self-persistent and resistant to PGE2 inhibition. | Front Immunol | 2026 | 42433369 | PubTator, text mining | PubMed |
| Natural and Engineered Cytokines as Cancer Therapeutics. | Annu Rev Cancer Biol | 2026 | 42428769 | PubTator, text mining | PubMed |
1 to 10 of 2,328
See all 2,328 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3601
GET https://conductscience.org/api/genes/v1/3601/patents?page=2